|
| ID |
DDInter237 |
| Drug Type |
small molecule |
| Molecular Formula |
C12H21N3O5S3 |
| Molecular Weight |
383.514
|
| Description |
Brinzolamide is a carbonic anhydrase inhibitor used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
|
| ATC Classification |
S01EC54
S01EC04
G01AE10
|
| IUPAC Name |
(4R)-4-(Ethylamino)-2-(3-Methoxypropyl)-1,1-Dioxo-2H,3H,4H-1Λ⁶-Thieno[3,2-E][1,2]Thiazine-6-Sulfonamide |
| InChI |
Inchi=1S/C12H21N3O5S3/C1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/H7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/T10-/M0/S1 |
| InChI Key |
HCRKCZRJWPKOAR-JTQLQIEISA-N |
| Canonical SMILES |
CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O |
| Useful Links |
DrugBank
ChEMBL
PubChem
|